MENU

Lyra Therapeutics (LYRA) Earnings Date & Reports

A.I. Advisor
published Earnings

LYRA is expected to report earnings to fall 6.03% to -32 cents per share on August 06

Lyra Therapeutics LYRA Stock Earnings Reports
Q2'24
Est.
$-0.33
Q1'24
Missed
by $0.09
Q4'23
Beat
by $0.13
Q3'23
Beat
by $0.05
Q2'23
Beat
by $0.06
The last earnings report on April 30 showed earnings per share of -34 cents, missing the estimate of -25 cents. With 151.75K shares outstanding, the current market capitalization sits at 17.37M.
View a ticker or compare two or three
LYRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com